|
Ezlopitant (CJ-11,974) is an NK1 receptor antagonist. It has antiemetic and antinociceptive effects. Pfizer was developing ezlopitant for the treatment of irritable bowel syndrome but it appears to have been discontinued. == See also == * NK1 receptor antagonist *Maropitant (tert-butyl instead of isopropyl) 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Ezlopitant」の詳細全文を読む スポンサード リンク
|